BIONOMICS LIMITED - Announcements

Currently unlisted. Add to my watchlist

Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical... Bionomics Limited (Bionomics) is an Australia-bases clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of novel, ion channel targeting drug candidates designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders. The Company operates in drug development segment in Australia. The Company is advancing its lead drug candidate, BNC210, which is an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder (SAD) and chronic treatment of Post-Traumatic Stress Disorder (PTSD). The Company has two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer’s disease and other central nervous system conditions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/19	369.07KB	Share
BNO	BNO at Neuroscience Innovation Forum and Biotech Showcase		04/01/19	106.78KB	Share
BNO	BNC105 Clinical Trial In Combination With Nivolumab	PRICE SENSITIVE	04/01/19	142.39KB	Share
BNO	Bionomics Receives $650k Licensing Revenue from CTx	PRICE SENSITIVE	21/12/18	77.03KB	Share
BNO	Appendix 3B		13/12/18	203.64KB	Share
BNO	Bionomics Receives Over $6.5m R&D Tax Incentive Refund	PRICE SENSITIVE	11/12/18	106.51KB	Share
BNO	SPP Completed		10/12/18	104.54KB	Share
BNO	Initial Director's Interest Notice		23/11/18	89.09KB	Share
BNO	Bionomics Share Purchase Plan Offer		22/11/18	409.8KB	Share
BNO	Change in substantial holding		20/11/18	1.18MB	Share
BNO	Cleansing Notice		16/11/18	80.59KB	Share
BNO	Appendix 3B		16/11/18	208.76KB	Share
BNO	Final Director's Interest Notice		15/11/18	118.11KB	Share
BNO	Executive Chairman Appointment - Material Contract Terms		15/11/18	103.37KB	Share
BNO	ASX Notification of Results 2018		14/11/18	86.35KB	Share
BNO	CEO 2018 AGM Presentation	PRICE SENSITIVE	14/11/18	1.7MB	Share
BNO	Executive Chairman 2018 AGM Presentation	PRICE SENSITIVE	14/11/18	532.94KB	Share
BNO	FUND RAISING UPDATE	PRICE SENSITIVE	14/11/18	121.77KB	Share
BNO	Capital Raise Update and Conference/Webcast Call		13/11/18	335.3KB	Share
BNO	Capital Raise Update and Conference Call		12/11/18	337.56KB	Share
BNO	Trading Halt	PRICE SENSITIVE	12/11/18	299.32KB	Share
BNO	Recapitalisation by major US-based biotechnology investor	PRICE SENSITIVE	09/11/18	101.83KB	Share
BNO	Leadership Changes and Strategic Review	PRICE SENSITIVE	09/11/18	99.71KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	29/10/18	264.69KB	Share
BNO	Appendix 4G / Corporate Governance Statement		12/10/18	314.71KB	Share
BNO	Bionomics Annual Report 2018		12/10/18	2.79MB	Share
BNO	Notice of Annual General Meeting/Proxy Form		12/10/18	471.09KB	Share
BNO	Change in substantial holding		05/10/18	310.23KB	Share
BNO	Bionomics' PTSD Trail Results Presentation	PRICE SENSITIVE	02/10/18	948.2KB	Share
BNO	Bionomics' PTSD Trial Results	PRICE SENSITIVE	02/10/18	120.84KB	Share
BNO	Trading Halt	PRICE SENSITIVE	28/09/18	135.47KB	Share
BNO	BNO to Host KOL Call on BNC210 and Treatment of Agitation		04/09/18	99.69KB	Share
BNO	Date of 2018 Annual General Meeting		31/08/18	77.9KB	Share
BNO	Appendix 3B		24/08/18	408.75KB	Share
BNO	Securities Trading Policy		17/08/18	165.46KB	Share
BNO	Full Year Statutory Accounts		16/08/18	1.23MB	Share
BNO	Bionomics 2017/2018 Preliminary Final Results	PRICE SENSITIVE	16/08/18	197.44KB	Share
BNO	Bionomics Presents at Annual Bioshares Biotech Summit		27/07/18	1.23MB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	20/07/18	258.5KB	Share
BNO	End-of-Treatment Milestone Met in Phase 2 PTSD Trial	PRICE SENSITIVE	09/07/18	110.08KB	Share
BNO	Appendix 3B		02/07/18	209.1KB	Share
BNO	Bionomics NOW Newsletter June 2018		25/06/18	622.68KB	Share
BNO	Ceasing to be a substantial holder		15/06/18	104.62KB	Share
BNO	Appendix 3B		08/06/18	209.13KB	Share
BNO	Commencement of BNC210 Phase 2 Agitation Trial	PRICE SENSITIVE	23/05/18	115.67KB	Share
BNO	Appendix 3B		07/05/18	187.88KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18	204.65KB	Share
BNO	Appendix 3B		20/04/18	187.55KB	Share
BNO	Bionomics Presents BNC101 and BNC105 Data at AACR Conference	PRICE SENSITIVE	13/04/18	178.7KB	Share
BNO	Phase 2 PTSD Clinical Trial Fully Recruited		11/04/18	172.5KB	Share
BNO	Appendix 3B		09/04/18	187.47KB	Share
BNO	Bionomics to Host KOL Meetings in New York and London		06/04/18	109.82KB	Share
BNO	Appendix 3B		29/03/18	411.13KB	Share
BNO	Appendix 3B		16/03/18	187.7KB	Share
BNO	Change in substantial holding		05/03/18	210.92KB	Share
BNO	Half Yearly Report and Accounts	PRICE SENSITIVE	14/02/18	862.69KB	Share
BNO	Bionomics NOW Newsletter February 2018		05/02/18	1.61MB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/18	460.46KB	Share
BNO	Bionomics Receives Over $6.7m R&D Tax Incentive Refund	PRICE SENSITIVE	16/01/18	90.45KB	Share
BNO	BNO to Feature at NIF and Biotech Showcase in San Francisco		05/01/18	210.88KB	Share
BNO	Change of Director's Interest Notice		18/12/17	256.46KB	Share
BNO	Appendix 3B		18/12/17	713.62KB	Share
BNO	Change of Director's Interest Notice		08/12/17	133.05KB	Share
BNO	Appendix 3B		08/12/17	187.75KB	Share
BNO	Change of Director's Interest Notice		24/11/17	130.03KB	Share
BNO	Appendix 3B		24/11/17	188.12KB	Share
BNO	Results of Meeting		15/11/17	138.45KB	Share
BNO	CEO & Managering Director's Report to Shareholders		15/11/17	1.09MB	Share
BNO	Chairman's Address to Shareholders		15/11/17	303.02KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/17	452.51KB	Share
BNO	BNC101 Phase 1 Clinical Trial Recruitment Completed	PRICE SENSITIVE	31/10/17	97.54KB	Share
BNO	Appendix 3B		30/10/17	187.79KB	Share
BNO	Bionomics & MSD to Host 5th Annual Neuroscience Symposium		26/10/17	94.58KB	Share
BNO	Appendix 4G / Corporate Governance Statement		13/10/17	274.12KB	Share
BNO	Notice of Annual General Meeting/Proxy Form		13/10/17	418.24KB	Share
BNO	Bionomics Annual Report 2017		13/10/17	2.54MB	Share
BNO	ASX Spotlight New York Presentation		12/10/17	102.29KB	Share
BNO	Change of Director's Interest Notice		04/10/17	119.07KB	Share
BNO	Appendix 3B		04/10/17	188.27KB	Share
BNO	Date of 2017 Annual General Meeting		12/09/17	47.25KB	Share
BNO	Appendix 3B		06/09/17	720.16KB	Share
BNO	Bionomics to Present at Rodman & Renshaw Conference		04/09/17	135.96KB	Share
BNO	Bionomics BNC210 to Feature at the 30th ECNP Congress		01/09/17	138.74KB	Share
BNO	Appendix 3B		21/08/17	709.07KB	Share
BNO	Bionomics & MSD 5th Annual Neuroscience Symposium		21/08/17	449.77KB	Share
BNO	Change of Director's Interest Notice		18/08/17	257.4KB	Share
BNO	Full Year Statutory Accounts		16/08/17	1.73MB	Share
BNO	Bionomics 2016/2017 Preliminary Final Results	PRICE SENSITIVE	16/08/17	280.54KB	Share
BNO	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/17	394.74KB	Share
BNO	Bionomics Added to OTCQX Composite and International Indices		24/07/17	133.85KB	Share
BNO	Bionomics Presents at 13th Annual Bioshares Biotech Summit		21/07/17	89.14KB	Share
BNO	Appendix 3B		18/07/17	736.91KB	Share
BNO	Appendix 3B		28/06/17	710.76KB	Share
BNO	Change in substantial holding		20/06/17	268.95KB	Share
BNO	Bionomics Presents on BNC210 at PTSD State of Science Summit		15/06/17	151.43KB	Share
BNO	Becoming a substantial holder (revised form)		08/06/17	176.3KB	Share
BNO	Becoming a substantial holder		08/06/17	176.12KB	Share
BNO	Ceasing to be a substantial holder		07/06/17	102.15KB	Share
BNO	Bionomics Corporate Presentation May 2017	PRICE SENSITIVE	31/05/17	2.03MB	Share
BNO	Bionomics NOW Newsletter May 2017		29/05/17	383.55KB	Share

BNO Appendix 4C - quarterly
31/01/19	PRICE SENSITIVE	369.07KB	Share
BNO BNO at Neuroscience Innovation Forum and Biotech Showcase
04/01/19		106.78KB	Share
BNO BNC105 Clinical Trial In Combination With Nivolumab
04/01/19	PRICE SENSITIVE	142.39KB	Share
BNO Bionomics Receives $650k Licensing Revenue from CTx
21/12/18	PRICE SENSITIVE	77.03KB	Share
BNO Appendix 3B
13/12/18		203.64KB	Share
BNO Bionomics Receives Over $6.5m R&D Tax Incentive Refund
11/12/18	PRICE SENSITIVE	106.51KB	Share
BNO SPP Completed
10/12/18		104.54KB	Share
BNO Initial Director's Interest Notice
23/11/18		89.09KB	Share
BNO Bionomics Share Purchase Plan Offer
22/11/18		409.8KB	Share
BNO Change in substantial holding
20/11/18		1.18MB	Share
BNO Cleansing Notice
16/11/18		80.59KB	Share
BNO Appendix 3B
16/11/18		208.76KB	Share
BNO Final Director's Interest Notice
15/11/18		118.11KB	Share
BNO Executive Chairman Appointment - Material Contract Terms
15/11/18		103.37KB	Share
BNO ASX Notification of Results 2018
14/11/18		86.35KB	Share
BNO CEO 2018 AGM Presentation
14/11/18	PRICE SENSITIVE	1.7MB	Share
BNO Executive Chairman 2018 AGM Presentation
14/11/18	PRICE SENSITIVE	532.94KB	Share
BNO FUND RAISING UPDATE
14/11/18	PRICE SENSITIVE	121.77KB	Share
BNO Capital Raise Update and Conference/Webcast Call
13/11/18		335.3KB	Share
BNO Capital Raise Update and Conference Call
12/11/18		337.56KB	Share
BNO Trading Halt
12/11/18	PRICE SENSITIVE	299.32KB	Share
BNO Recapitalisation by major US-based biotechnology investor
09/11/18	PRICE SENSITIVE	101.83KB	Share
BNO Leadership Changes and Strategic Review
09/11/18	PRICE SENSITIVE	99.71KB	Share
BNO Appendix 4C - quarterly
29/10/18	PRICE SENSITIVE	264.69KB	Share
BNO Appendix 4G / Corporate Governance Statement
12/10/18		314.71KB	Share
BNO Bionomics Annual Report 2018
12/10/18		2.79MB	Share
BNO Notice of Annual General Meeting/Proxy Form
12/10/18		471.09KB	Share
BNO Change in substantial holding
05/10/18		310.23KB	Share
BNO Bionomics' PTSD Trail Results Presentation
02/10/18	PRICE SENSITIVE	948.2KB	Share
BNO Bionomics' PTSD Trial Results
02/10/18	PRICE SENSITIVE	120.84KB	Share
BNO Trading Halt
28/09/18	PRICE SENSITIVE	135.47KB	Share
BNO BNO to Host KOL Call on BNC210 and Treatment of Agitation
04/09/18		99.69KB	Share
BNO Date of 2018 Annual General Meeting
31/08/18		77.9KB	Share
BNO Appendix 3B
24/08/18		408.75KB	Share
BNO Securities Trading Policy
17/08/18		165.46KB	Share
BNO Full Year Statutory Accounts
16/08/18		1.23MB	Share
BNO Bionomics 2017/2018 Preliminary Final Results
16/08/18	PRICE SENSITIVE	197.44KB	Share
BNO Bionomics Presents at Annual Bioshares Biotech Summit
27/07/18		1.23MB	Share
BNO Appendix 4C - quarterly
20/07/18	PRICE SENSITIVE	258.5KB	Share
BNO End-of-Treatment Milestone Met in Phase 2 PTSD Trial
09/07/18	PRICE SENSITIVE	110.08KB	Share
BNO Appendix 3B
02/07/18		209.1KB	Share
BNO Bionomics NOW Newsletter June 2018
25/06/18		622.68KB	Share
BNO Ceasing to be a substantial holder
15/06/18		104.62KB	Share
BNO Appendix 3B
08/06/18		209.13KB	Share
BNO Commencement of BNC210 Phase 2 Agitation Trial
23/05/18	PRICE SENSITIVE	115.67KB	Share
BNO Appendix 3B
07/05/18		187.88KB	Share
BNO Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE	204.65KB	Share
BNO Appendix 3B
20/04/18		187.55KB	Share
BNO Bionomics Presents BNC101 and BNC105 Data at AACR Conference
13/04/18	PRICE SENSITIVE	178.7KB	Share
BNO Phase 2 PTSD Clinical Trial Fully Recruited
11/04/18		172.5KB	Share
BNO Appendix 3B
09/04/18		187.47KB	Share
BNO Bionomics to Host KOL Meetings in New York and London
06/04/18		109.82KB	Share
BNO Appendix 3B
29/03/18		411.13KB	Share
BNO Appendix 3B
16/03/18		187.7KB	Share
BNO Change in substantial holding
05/03/18		210.92KB	Share
BNO Half Yearly Report and Accounts
14/02/18	PRICE SENSITIVE	862.69KB	Share
BNO Bionomics NOW Newsletter February 2018
05/02/18		1.61MB	Share
BNO Appendix 4C - quarterly
31/01/18	PRICE SENSITIVE	460.46KB	Share
BNO Bionomics Receives Over $6.7m R&D Tax Incentive Refund
16/01/18	PRICE SENSITIVE	90.45KB	Share
BNO BNO to Feature at NIF and Biotech Showcase in San Francisco
05/01/18		210.88KB	Share
BNO Change of Director's Interest Notice
18/12/17		256.46KB	Share
BNO Appendix 3B
18/12/17		713.62KB	Share
BNO Change of Director's Interest Notice
08/12/17		133.05KB	Share
BNO Appendix 3B
08/12/17		187.75KB	Share
BNO Change of Director's Interest Notice
24/11/17		130.03KB	Share
BNO Appendix 3B
24/11/17		188.12KB	Share
BNO Results of Meeting
15/11/17		138.45KB	Share
BNO CEO & Managering Director's Report to Shareholders
15/11/17		1.09MB	Share
BNO Chairman's Address to Shareholders
15/11/17		303.02KB	Share
BNO Appendix 4C - quarterly
31/10/17	PRICE SENSITIVE	452.51KB	Share
BNO BNC101 Phase 1 Clinical Trial Recruitment Completed
31/10/17	PRICE SENSITIVE	97.54KB	Share
BNO Appendix 3B
30/10/17		187.79KB	Share
BNO Bionomics & MSD to Host 5th Annual Neuroscience Symposium
26/10/17		94.58KB	Share
BNO Appendix 4G / Corporate Governance Statement
13/10/17		274.12KB	Share
BNO Notice of Annual General Meeting/Proxy Form
13/10/17		418.24KB	Share
BNO Bionomics Annual Report 2017
13/10/17		2.54MB	Share
BNO ASX Spotlight New York Presentation
12/10/17		102.29KB	Share
BNO Change of Director's Interest Notice
04/10/17		119.07KB	Share
BNO Appendix 3B
04/10/17		188.27KB	Share
BNO Date of 2017 Annual General Meeting
12/09/17		47.25KB	Share
BNO Appendix 3B
06/09/17		720.16KB	Share
BNO Bionomics to Present at Rodman & Renshaw Conference
04/09/17		135.96KB	Share
BNO Bionomics BNC210 to Feature at the 30th ECNP Congress
01/09/17		138.74KB	Share
BNO Appendix 3B
21/08/17		709.07KB	Share
BNO Bionomics & MSD 5th Annual Neuroscience Symposium
21/08/17		449.77KB	Share
BNO Change of Director's Interest Notice
18/08/17		257.4KB	Share
BNO Full Year Statutory Accounts
16/08/17		1.73MB	Share
BNO Bionomics 2016/2017 Preliminary Final Results
16/08/17	PRICE SENSITIVE	280.54KB	Share
BNO Appendix 4C - quarterly
27/07/17	PRICE SENSITIVE	394.74KB	Share
BNO Bionomics Added to OTCQX Composite and International Indices
24/07/17		133.85KB	Share
BNO Bionomics Presents at 13th Annual Bioshares Biotech Summit
21/07/17		89.14KB	Share
BNO Appendix 3B
18/07/17		736.91KB	Share
BNO Appendix 3B
28/06/17		710.76KB	Share
BNO Change in substantial holding
20/06/17		268.95KB	Share
BNO Bionomics Presents on BNC210 at PTSD State of Science Summit
15/06/17		151.43KB	Share
BNO Becoming a substantial holder (revised form)
08/06/17		176.3KB	Share
BNO Becoming a substantial holder
08/06/17		176.12KB	Share
BNO Ceasing to be a substantial holder
07/06/17		102.15KB	Share
BNO Bionomics Corporate Presentation May 2017
31/05/17	PRICE SENSITIVE	2.03MB	Share
BNO Bionomics NOW Newsletter May 2017
29/05/17		383.55KB	Share

REFRESH

First 2 3 4 5 6

BIONOMICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available